Share chart Rain Therapeutics Inc.
Extended chart
Simple chart
About Rain Therapeutics Inc.
Rain Therapeutics Inc., компания, занимающаяся прецизионной онкологией, занимается разработкой методов лечения онкогенных факторов в Соединенных Штатах. Его ведущим кандидатом в продукт является RAIN-32, низкомолекулярный пероральный ингибитор мышиной двойной минуты 2, который является онкогенным при различных раковых заболеваниях. more details| IPO date | 2021-04-23 |
|---|---|
| ISIN | US75082Q1058 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.rainthera.com |
| Цена ао | 1.21 |
| Change price per day: | 0% (1.21) |
|---|---|
| Change price per week: | 0% (1.21) |
| Change price per month: | 0% (1.21) |
| Change price per 3 month: | 0% (1.21) |
| Change price per half year: | 0% (1.21) |
| Change price per year: | 0% (1.21) |
| Change price per 3 year: | -82.15% (6.78) |
| Change price per 5 year: | 0% (1.21) |
| Change price per 10 year: | 0% (1.21) |
| Change price per year to date: | 0% (1.21) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Tang Capital Management, LLC | 3740341 | 13.56 |
| BVF Inc. | 3526729 | 12.79 |
| Samsara BioCapital, LLC | 2034552 | 7.38 |
| Boxer Capital, LLC | 1152212 | 4.18 |
| Blackrock Inc. | 1015385 | 3.68 |
| Vanguard Group Inc | 902664 | 3.27 |
| Acadian Asset Management. LLC | 609916 | 2.21 |
| Acuitas Investments LLC | 409256 | 1.48 |
| Russell Investments Group, Ltd. | 395935 | 1.44 |
| Geode Capital Management, LLC | 329216 | 1.19 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares MSCI India Small-Cap ETF | 0.09335 | 0.4625 | 0.96163 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.03802 | 7.67 | 2.7853 |
WisdomTree India Earnings Fund
|
0.03677 | 5.23 | 1.65591 |
| Dimensional Emerging Markets Value ETF | 0.03604 | 17.07 | 4.19508 |
| SPDR S&P Emerging Markets Small Cap ETF | 0.035 | 5.46 | 3.03583 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.01754 | 15.96 | 3.34087 |
| PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF | 0.0105 | 2.43 | 4.35382 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.01 | 9.39 | 3.09932 |
| SPDR Portfolio Emerging Markets ETF | 0.00615 | 11.59 | 3.1879 |
| Avantis Emerging Markets Equity ETF | 0.00374 | 8.77 | 3.60513 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00333 | 13.06 | 3.62488 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Avanish Vellanki M.B.A. | Co-Founder, CEO & Chairman | 959.75k | 1975 (50 years) |
| Dr. Robert C. Doebele M.D., Ph.D. | Co-Founder, Chairman of Scientific Advisory Board, President & CSO and Chief Medical Officer | 700.56k | 1971 (54 years) |
| Ms. Vijaya Tirunagaru Ph.D. | Senior VP & Head of Research | N/A | |
| Mr. Erik Atkisson | General Counsel & Chief Compliance Officer | N/A | 1972 (53 years) |
| Ms. Charmi Turner | Vice President of People & Culture | N/A | |
| Ms. Josephine Bruce | Principal Financial & Accounting officer | N/A | 1979 (46 years) |
| Dr. Nora Ku M.D. | MD & VP of Clinical Development | N/A | |
| Ms. Theresa O'Connell M.S. | Director of Corporate Development & Operations |
Address: United States, Newark, CA -, 8000 Jarvis Avenue - open in Google maps, open in Yandex maps
Website: http://www.rainthera.com
Website: http://www.rainthera.com
